1[1]Stein H, Mason DY, Gerdes J et al. The expression of the Hodgkin's disease associated antigen ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cell and histiocytic malignancies are derived from activated lymphoid cells. Blood, 1985;66:848～58
2[2]Kinney MC, Collins RD, Greer JP et al. A small cell predominant variant of primary ki-1 (CD30+) T-cell lymphoma. Am J Surg Pathol, 1993;17:859～68
3[3]Pileri S, Falini B, Delsol G et al. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma) CD30+/ki-1+ with a high content of reactive histiocytes. Histopathology, 1990;16:383～91
4[4]Mann KP, Hall B, Kamino H et al. Neutrophil-rich ki-1± anaplastic large cell malignant lymphoma. Am J Surg Pathol, 1995;19:407～16
5[5]Chan JKC, Buchanan R, Fletcher CDM. Sarcomatoid variant of anaplastic large cell ki-1 lymphoma. Am J Surg Pathol, 1990;14:383～90
6[6]Falini B, LisoA, Pasqualucci L et al. CD30+ anaplastic large cell lymphoma, null type, with signet-ring appearance. Histopathology, 1997;30:90～2
7[7]de Bruin PC, Beljaards RC, Heerde PV et al. Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology, 1993;23:127～35
8[8]Kinney MC, Greer GP, Kadin ME et al. P80NPM/ALK expression in ki-1+ lymphomas: histologic and immunophenotypic correlation. Lab Invest, 1996:74～81
6Franchina M,Kadin ME,Abraham LJ.Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders[J].Cancer Epidemiol Biomarkers Prey,2005,14(5):1 322-1 325.
7Vander Vegt B,Roos MA.The expression pattern of MUC1(EMA) is related to tumor characteristics and clinical outcome of invasive ductal breast carcinoma[J].Histopathol,2007,5 151(2):227-238.
